The Centers for Disease Control and Prevention has formally proposed incorporating a new inquiry into its annual National Health Interview Survey slated for 2028. This potential addition aims to evaluate both the frequency of cannabis consumption and the underlying motivations driving usage—specifically distinguishing between medical applications and recreational consumption. By systematically tracking whether respondents utilize cannabis for specific health conditions versus recreational enjoyment, federal public health tracking could soon yield more granular data regarding consumer habits.
For the commercial cannabis sector, this initiative marks another step toward the mainstream integration of cannabis into standard public health metrics. As federal agencies increasingly study the dividing line between medical and recreational markets, businesses can anticipate a growing body of demographic data that could influence future health policy, product positioning, and consumer education strategies.